PharmaShots | Incisive News in 3 Shots

Subscribe Now

Acute Ischemic Stroke

Biogen Exercises its Option to Acquire TMS-007 for Acute Ischemic Stroke

Biogen Exercises its Option to Acquire TMS-007 for Acute Ischemic Stroke

May 13, 2021

AstraZeneca Report Results of Brilinta (ticagrelor) in P-III THALES Study for Patients with Acute Ischemic Stroke or Transient Ischemic Attack

AstraZeneca Report Results of Brilinta (ticagrelor) in P-III THALES Study for Patients with Acute Ischemic Stroke or Transient Isc...

July 16, 2020

AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Priority Review for Reducing Stroke in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Priority Review for Reducing Stroke in Patients with Acute Ischemic Stro...

July 9, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us